GSK presses court to deny Teva’s ‘skinny label’ petition

25-08-2022

Sarah Speight

GSK presses court to deny Teva’s ‘skinny label’ petition

Willy Barton / Shutterstock.com

Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided.


GSK, Teva, skinny labelling, Coreg, Hatch-Waxman Act, SCOTUS

LSIPR